{"id":"W4413117443","doi":"10.1016/j.ejim.2025.07.020","title":"A person-centred clinical approach to the multimorbid patient with COPD","year":2025,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Novartis Pharma; Mereo BioPharma; AOP Orphan; Swedish Orphan Biovitrum; Galápagos; Moderna; Pfizer; Incyte; Insmed; ResMed; Genentech; Veracyte; Amicus Therapeutics; Cerecor; Regeneron Pharmaceuticals; Intuitive Surgical; Bayer; Gilead Sciences; Sanofi; COPD Foundation; United Therapeutics Corporation; Massachusetts General Hospital; Lung Foundation Australia; GlaxoSmithKline; National Institute for Health and Care Research; CSL Behring; Chiesi Farmaceutici; Eli Lilly and Company; AstraZeneca; Patient-Centered Outcomes Research Institute; Pulmonary Fibrosis Foundation; Amgen; NGM Biopharmaceuticals","keywords":"Medicine; COPD; Comorbidity; Multimorbidity; Intensive care medicine; Quality of life (healthcare); Disease; MEDLINE; Disease management; Delphi method; Disease burden; Physical therapy; Internal medicine; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05542814,0.000998644,0.0021662,0.002405005,0.005177519,0.007053018,0.004805377,0.01261137,0.007952604],"category_scores_gemma":[0.1772115,0.0008207049,0.002425595,0.002444546,0.007017568,0.008558059,0.01049882,0.01878298,0.002188256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01118568,"about_ca_system_score_gemma":0.03607046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01463193,"about_ca_topic_score_gemma":0.02565676,"domain_scores_codex":[0.861982,0.1145416,0.008319349,0.004746938,0.008212329,0.002197768],"domain_scores_gemma":[0.8778738,0.07793259,0.005651925,0.003639315,0.02300621,0.01189613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0001470435,0.0001355913,0.003377886,0.02203043,0.0005785894,0.002005939,0.04917851,0.001397557,0.0005371319,0.04408053,0.6732215,0.2033092],"study_design_scores_gemma":[0.0002181964,0.0003008808,0.004865756,0.04562113,0.0002956465,0.002826022,0.02921075,0.001236483,0.000251695,0.07297118,0.8419679,0.0002343524],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.00174804,0.03787997,0.01745362,0.9185964,0.01288204,0.001250542,0.0002529369,0.0001287676,0.009807713],"genre_scores_gemma":[0.1321496,0.08112729,0.0833269,0.6561832,0.02822245,0.008600193,0.0005041499,0.0002114036,0.009674801],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05542814,"threshold_uncertainty_score":0.2931356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05202035915197409,"score_gpt":0.3305998123753949,"score_spread":0.2785794532234208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}